Steven Cohen Caribou Biosciences, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 3,585,018 shares of CRBU stock, worth $10.3 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,585,018
Previous 3,521,376
1.81%
Holding current value
$10.3 Million
Previous $20.2 Million
8.68%
% of portfolio
0.05%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding CRBU
# of Institutions
158Shares Held
67.4MCall Options Held
111KPut Options Held
105K-
Black Rock Inc. New York, NY7.01MShares$20.2 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA6.48MShares$18.7 Million1.64% of portfolio
-
State Street Corp Boston, MA6.35MShares$18.3 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX5.79MShares$16.7 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.11MShares$11.8 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $175M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...